MedTrace Logo

The Effectiveness of rTMS in Depressed VA Patients

NCT01191333 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 164

Last updated 2018-03-09

Study results available
· View outcomes & findings →

Summary

The purpose of this multi-site trial is to determine if repetitive Transcranial Magnetic Stimulation (rTMS) helps people with depression who have not been helped by medications or who have not been helped enough by medications.

Conditions

Interventions

DEVICE

rTMS

Repetitive Transcranial Magnetic Stimulation

DEVICE

Sham Device

Placebo Device that simulates active rTMS treatment

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Jerome A. Yesavage, MD · VA Palo Alto Health Care System, Palo Alto, CA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-02
Primary Completion
2017-02-15
Completion
2017-03-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01191333 on ClinicalTrials.gov